Nuvectis Pharma Inc (NVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 4,643 | 4,396 | 6,866 | 6,158 | 5,772 |
| Operating Income | -4,643 | -4,396 | -6,866 | -6,158 | -5,772 |
| Other Income | 215 | 225 | 244 | 277 | 64 |
| Pre-tax Income | -4,428 | -4,171 | -6,622 | -5,881 | -5,708 |
| Net Income Continuous | -4,428 | -4,171 | -6,622 | -5,881 | -5,708 |
| Net Income | $-4,428 | $-4,171 | $-6,622 | $-5,881 | $-5,708 |
| EPS Basic Total Ops | -0.26 | -0.25 | -0.41 | -0.37 | -0.38 |
| EPS Basic Continuous Ops | -0.26 | -0.25 | -0.41 | -0.37 | -0.38 |
| EPS Diluted Total Ops | -0.26 | -0.25 | -0.41 | -0.37 | -0.38 |
| EPS Diluted Continuous Ops | -0.26 | -0.25 | -0.41 | -0.37 | -0.38 |
| EPS Diluted Before Non-Recurring Items | -0.26 | -0.25 | -0.41 | N/A | N/A |
| EBITDA(a) | $-4,643 | $-4,396 | $-6,866 | $-6,158 | $-5,772 |